Thrombin and platelet activation

Chest

Volumn 124, Issue 3 SUPPL., 2003, Pages 18S-25S

  Brass, Lawrence F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

G protein coupled receptors; G proteins; Phospholipase C; Platelet; Protease activated receptors; Thrombin

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENYLATE CYCLASE; ANTITHROMBOCYTIC AGENT; BLOOD CLOTTING FACTOR 10A; CD39 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; COLLAGEN; CYCLIC AMP; DIPYRIDAMOLE; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE DIPHOSPHATE; PHOSPHOLIPASE C; PROSTACYCLIN; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 3; PROTEINASE ACTIVATED RECEPTOR 4; THROMBIN; THROMBIN INHIBITOR; THROMBIN RECEPTOR; THROMBOXANE A2; VON WILLEBRAND FACTOR;

BINDING SITE; BLOOD VESSEL INJURY; CELL MEMBRANE; CYTOSKELETON; HEMOSTASIS; HUMAN; LEUKOCYTE; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE ACTIVATION;

EID: 0141484537     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.124.3_suppl.18S     Document Type: Article

References (49)

1. Vu TKH, Hung DT, Wheaton VI, et al. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64:1057-1068
2. Rasmussen UB, Vouret-Craviari V, Jallat S, et al. cDNA cloning and expression of a hamster α-thrombin receptor coupled to Ca2+ mobilization. FEBS Lett 1991; 288:123-128
3. Moake JL. Thrombotic microangiopathies. N Engl J Med 2002; 347:589-600
4. Murata T, Ushikubi F, Matsuoka T, et al. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature 1997; 388:678-682
5. Marcus AJ, Broekman MJ, Drosopoulos JH, et al. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Invest 1997; 99:1351-1360
6. Gayle RB III, Maliszewski CR, Gimpel SD, et al. Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39. J Clin Invest 1998; 101:1851-1859
7. Falati S, Gross P, Merrill-Skoloff G, et al. Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat Med 2002; 8:1175-1181
8. Gross BS, Lee JR, Clements JL, et al. Tyrosine phosphorylation of SLP-76 is downstream of Syk following stimulation of the collagen receptor in platelets. J Biol Chem 1999; 274:5963-5971
9. Hamm HE. How activated receptors couple to G proteins. Proc Natl Acad Sci U S A 2001; 98:4819-4821
10. 2 and thrombin receptors in human platelets. Proc Natl Acad Sci U S A 1994; 91:504-508
11. Klages B, Brandt U, Simon MI, et al. Activation of G12/G13 results in shape change and Rho/Rho-kinase-mediated myosin light chain phosphorylation in mouse platelets. J Cell Biol 1999; 144:745-754
12. Offermanns S, Toombs CF, Hu YH, et al. Defective platelet activation in G alpha(q)-deficient mice. Nature 1997; 389:183-186
13. Offermanns S, Simon MI. Genetic analysis of mammalian G-protein signalling. Oncogene 1998; 17:1375-1381
14. Woulfe D, Yang J, Prevost N, et al. Signal transduction during the initiation, extension and perpetuation of platelet plug formation. In: Michelson AD, ed. Platelets. New York, NY: Academic Press; 2002; 197-214
15. Yang J, Wu J, Jiang H, et al. Signaling through Gi family members in platelets: redundancy and specificity in the regulation of adenylyl cyclase and other effectors. J Biol Chem 2002; 277:46035-46042
16. Yang J, Wu J, Kowalska MA, et al. Loss of signaling through the G protein, Gz, results in abnormal platelet activation and altered responses to psychoactive drugs. Proc Natl Acad Sci U S A 2000; 97:9984-9989
17. Jantzen HM, Milstone DS, Gousset L, et al. Impaired activation of murine platelets lacking G alpha(i2). J Clin Invest 2001; 108:477-483
18. Woulfe D, Jiang H, Mortensen R, et al. Activation of Rap1B by G(i) family members in platelets. J Biol Chem 2002; 277:23382-23390
19. Jin J, Kunapuli SP. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proc Natl Acad Sci U S A 1998; 95:8070-8074
20. Hollopeter G, Jantzen HM, Vincent D, et al. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 2001; 409:202-207
21. Foster CJ, Prosser DM, Agans JM, et al. Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. J Clin Invest 2001; 107:1591-1598
22. Gachet C. ADP receptors of platelets and their inhibition. Thromb Haemost 2001; 86:222-232
23. Phillips DR, Nannizzi-Alaimo L, Prasad KS. Beta3 tyrosine phosphorylation in alphaIIbbeta3 (platelet membrane GP IIb-IIIa) outside-in integrin signaling. Thromb Haemost 2001; 86:246-258
24. Prevost N, Woulfe D, Tanaka T, et al. Interactions between Eph kinases and ephrins provide a mechanism to support platelet aggregation once cell-to-cell contact has occurred. Proc Natl Acad Sci U S A 2002; 99:9219-9224
25. Andre P, Nannizzi-Alaimo L, Prasad SK, et al. Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation 2002; 106:896-899
26. Harmon JT, Jamieson GA. Thrombin binds to a high-affinity approximately 900,000-Dalton site on human platelets. Biochemistry 1985; 24:58-64
27. Harmon JT, Jamieson GA. The glycocalicin portion of platelet glycoprotein Ib expresses both high and moderate affinity binding sites for thrombin. J Biol Chem 1986; 261:13224-13229
28. Nystedt S, Emilsson K, Wahlestedt C, et al. Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci U S A 1994; 91:9208-9212
29. Nystedt S, Emilsson K, Larsson AK, et al. Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor 2. Eur J Biochem 1995; 232:84-89
30. Parry MA, Myles T, Tschopp J, et al. Cleavage of the thrombin receptor: identification of potential activators and inactivators. Biochem J 1996; 320:335-341
31. Camerer E, Huang W, Coughlin SR. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci U S A 2000; 97:5255-5260
32. Camerer E, Rottingen JA, Gjernes E, et al. Coagulation factors VIIa and Xa induce cell signaling leading to up-regulation of the egr-1 gene. J Biol Chem 1999; 274:32225-32233
33. Connolly AJ, Ishihara H, Kahn ML, et al. Role of the thrombin receptor in development and evidence for a second receptor. Nature 1996; 381:516-519
34. Ishihara H, Connolly AJ, Zeng D, et al. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 1997; 386:502-506
35. Nakanishi-Matsui M, Zheng YW, Sulciner DJ, et al. PAR3 is a cofactor for PAR4 activation by thrombin. Nature 2000; 404:609-613
36. Kahn ML, Zheng YW, Huang W, et al. A dual thrombin receptor system for platelet activation. Nature 1998; 394:690-694
37. Xu WF, Andersen H, Whitmore TE, et al. Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci U S A 1998; 95:6642-6646
38. Kahn ML, Nakanishi-Matsui M, Shapiro MJ, et al. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest 1999; 103:879-887
39. Sambrano GR, Weiss EJ, Zheng YW, et al. Role of thrombin signalling in platelets in haemostasis and thrombosis. Nature 2001; 413:74-78
40. Ishii K, Gerszten R, Zheng YW, et al. Determinants of thrombin receptor cleavage: receptor domains involved, specificity, and role of the P3 aspartate. J Biol Chem 1995; 270:16435-16440
41. Covic L, Gresser AL, Kuliopulos A. Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets. Biochemistry 2000; 39:5458-5467
42. Shapiro MJ, Weiss EJ, Faruqi TR, et al. Protease-activated receptors 1 and 4 are shut off with distinct kinetics after activation by thrombin. J Biol Chem 2000; 275:25216-25221
43. Lopez JA, Andrews RK, Afshar-Kharghan V, et al. Bernard-Soulier syndrome. Blood 1998; 91:4397-4418
44. De Cristofaro R, De Candia E, Rutella S, et al. The Asp(272)-Glu(282) region of platelet glycoprotein Ibalpha interacts with the heparin-binding site of α-thrombin and protects the enzyme from the heparin-catalyzed inhibition by antithrombin III. J Biol Chem 2000; 275:3887-3895
45. De Marco L, Mazzucato M, Masotti A, et al. Function of glycoprotein Ib α in platelet activation induced by alpha-thrombin. J Biol Chem 1991; 266:23776-23783
46. Harmon JT, Jamieson GA. Platelet activation by thrombin in the absence of the high-affinity thrombin receptor. Biochemistry 1988; 27:2151-2157
47. Mazzucato M, Marco LD, Masotti A, et al. Characterization of the initial α-thrombin interaction with glycoprotein Ib alpha in relation to platelet activation. J Biol Chem 1998; 273:1880-1887
48. De Candia E, Hall SW, Rutella S, et al. Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of Par-1 on intact platelets. J Biol Chem 2001; 276:4692-4698
49. O'Brien PJ, Molino M, Kahn M, et al. Protease activated receptors: theme and variations. Oncogene 2001; 20:1570-1581